[1] BRUIX J,GORES GJ,MAZZAFERRO V.Hepatocellular carcinoma:clinical frontiers and perspectives[J].Gut,2014,63(5):844.
[2] 段小飞,张水军.肝细胞癌微血管侵犯诊治[J/CD].中华肝脏外科手术学电子杂志,2017,6(2):150.
[3] 中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会,等.原发性肝癌规范化病理诊断指南(2015年版)[J].中华肝脏病杂志,2015,23(5):321.
[4] POPWACUI,IONESCUM,CIUREAS,et al.Current treatment of hepatocellular carcinoma.Analysis of a series of 123 case over a 5-year period[J].Chiruhia(Bucur),2005,100(4):321.
[5] 樊嘉,周俭,徐泱."上海标准"在肝癌肝移植适应症中应用13年的回顾分析[J].中华器官移植杂志,2013,34(9):521.
[6] BERTUZZO VR,CESCON M,RAVAIOLI M,et al.Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers[J].Transplantation,2011,91(11):1279.
[7] NEUMANN U.Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria (Br J Surg 2011;98:1292-1300)[J].Br J Surg,2011,98(9):1300.
[8] HUANG ZY,LIANG BY,XIONG M,et al.Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis:a single-center experience in China[J].Ann Surg Oncol,2012,19(8):2515.
[9] RODRÍGUEZ-PERÁLVAREZ M,LUONG TV,ANDREANA L,et al.A systematic review of microvascular invasion in hepatocellular carcinoma:diagnostic and prognostic and prognostic variability[J].Ann Surg Oncol,2013,20(1):325.
[10] LIU HY,QIAN HH,ZHANG XF,et al.Improved method increases sensitivity for circulating hepatocellular carcinoma cells[J].World J Gastroenterol,2015,21(10):2918.
[11] IGUCHI T,SHIRABE K,AISHIMA S,et al.New pathologic stratification of microvascular invasion in hepatocellular carcinoma:predicting prognosis after living-donor liverTransplantation[J].Transplantation,2015,99(6):1236.
[12]
[13] WHITTAKER S,MARAIS R,ZHU AX.The role of signaling pathways in the development and treatment of hepatocellular carcinoma[J].Oncogene,2010,29(36):4989.
[14] 汪宇,李锡锋,张小峰,等.术前外周血循环肿瘤细胞检测对原发性肝细胞肝癌微血管侵犯的预测价值[J].山东医药,2017,57(18):33.
[15] MC HUGH PP,GILBERT J,VERA S,et al.Alphafetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma[J].HPB,2010,12(1):56.
[16] KAIBORI M,ISHIZAKI M,MATSUI K,et al.Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma[J].J Surg Oncol,2010,102(5):462.
[17] CHOU CT,CHEN RC,LEE CW,et al.Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging[J].Br J Radiol,2012,85(1014):778.
[18] WITJES CD,WILLEMSSEN FE,VERHEIJ J,et al.Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI[J].JMRI,2012,36(3):641.
[19] LEI Z,LI J,WU D,et al.Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria[J].JAMA Surg,2016,151(4):356.